title: [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
authors.affiliation: Academisch Medisch Centrum, afd. Inwendige Geneeskunde, Amsterdam.
authors.forename: S J
authors.initials: SJ
authors.lastname: van Deventer
authors.forename: C J
authors.initials: CJ
authors.lastname: van der Linden
authors.forename: J J
authors.initials: JJ
authors.lastname: Roord
authors.forename: H
authors.initials: H
authors.lastname: Schellekens
authors.forename: J F
authors.initials: JF
authors.lastname: Schellekens
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic / Q000592:standards; D016905:Gram-Negative Bacterial Infections / Q000628:therapy; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use*; D018805:Sepsis / Q000628:therapy*; D012772:Shock, Septic / Q000628:therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C068069:nebacumab